杭州默佳生物科技有限公司

Member Center
Go
杭州默佳生物科技有限公司
 
新闻中心
副标题
Premier calls for deepening health reform
FENGHUA Launches New Quantitative Determination Reagents for HBV
Stryker announces definitive agreement to acquire NOVADAQ Technologies Inc.
PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion
New Random Access Chemiluminescent Assay for Inflammatory Bowel Disease Launched
top
Home Page
Member Center
PC version
中文版
中文
English


Faisco provides technical support | PC version
Message
Telephone
Map